EVOKE PHARMA, INC. Increase (Decrease) in Accounts Receivable
EVOKE PHARMA, INC. reported Increase (Decrease) in Accounts Receivable of $770.11 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2025-11-13
- EVOKE PHARMA, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $285.04K, a 1360.64% increase year-over-year.
- EVOKE PHARMA, INC. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $393.95K, a 28.52% decline year-over-year.
- EVOKE PHARMA, INC. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $91.12K, a 88.30% decline year-over-year.
- EVOKE PHARMA, INC. increase (decrease) in accounts receivable for the quarter ending 2024-12-31 was $397.86K.
- EVOKE PHARMA, INC. increase (decrease) in accounts receivable for fiscal 2024 was $1.75M, a 3522.18% increase from fiscal 2023.
- EVOKE PHARMA, INC. increase (decrease) in accounts receivable for fiscal 2023 was $48.24K, a 85.37% decline from fiscal 2022.
- EVOKE PHARMA, INC. increase (decrease) in accounts receivable for fiscal 2022 was $329.64K, a 21.24% increase from fiscal 2021.
- EVOKE PHARMA, INC. increase (decrease) in accounts receivable for fiscal 2021 was $271.88K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2025-09-30 | $285.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $679.00K derived: sum of 2 quarters · filed 2025-11-13 | $770.11K 10-Q · filed 2025-11-13 | $1.17M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $393.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $485.07K 10-Q · filed 2025-08-14 | $882.92K derived: sum of 3 quarters · filed 2025-08-14 | $902.44K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $91.12K 10-Q · filed 2025-05-13 | $488.97K derived: sum of 2 quarters · filed 2025-05-13 | $508.49K derived: sum of 3 quarters · filed 2025-11-13 | $1.06M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $397.86K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $417.37K derived: sum of 2 quarters · filed 2025-11-13 | $968.47K derived: sum of 3 quarters · filed 2025-11-13 | $1.75M 10-K · filed 2025-03-13 |
| 2024-09-30 | $19.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $570.61K derived: sum of 2 quarters · filed 2025-11-13 | $1.35M 10-Q · filed 2025-11-13 | $788.61K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $551.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.33M 10-Q · filed 2025-08-14 | $769.10K derived: sum of 3 quarters · filed 2025-08-14 | $979.19K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $778.83K 10-Q · filed 2025-05-13 | $218.00K derived: sum of 2 quarters · filed 2025-05-13 | $428.09K derived: sum of 3 quarters · filed 2025-05-13 | $764.60K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$560.83K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$350.74K derived: sum of 2 quarters · filed 2025-03-13 | -$14.23K derived: sum of 3 quarters · filed 2025-03-13 | $48.24K 10-K · filed 2025-03-13 |
| 2023-09-30 | $210.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $546.60K derived: sum of 2 quarters · filed 2024-11-07 | $609.07K 10-Q · filed 2024-11-07 | $558.93K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $336.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $398.98K 10-Q · filed 2024-08-13 | $348.84K derived: sum of 3 quarters · filed 2024-08-13 | $658.17K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $62.47K 10-Q · filed 2024-05-14 | $12.33K derived: sum of 2 quarters · filed 2024-05-14 | $321.66K derived: sum of 3 quarters · filed 2024-05-14 | $268.39K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$50.14K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | $259.19K derived: sum of 2 quarters · filed 2024-05-14 | $205.92K derived: sum of 3 quarters · filed 2024-05-14 | $329.64K 10-K/A · filed 2024-05-14 |
| 2022-09-30 | $309.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $256.06K derived: sum of 2 quarters · filed 2023-11-09 | $379.78K 10-Q · filed 2023-11-09 | $452.80K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$53.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $70.45K 10-Q · filed 2023-08-10 | $143.48K derived: sum of 3 quarters · filed 2023-08-10 | $167.23K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $123.72K 10-Q · filed 2023-05-15 | $196.74K derived: sum of 2 quarters · filed 2023-05-15 | $220.50K derived: sum of 3 quarters · filed 2023-05-15 | $291.12K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $73.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $96.78K derived: sum of 2 quarters · filed 2023-03-21 | $167.40K derived: sum of 3 quarters · filed 2023-03-21 | $271.88K 10-K · filed 2023-03-21 |
| 2021-09-30 | $23.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $94.37K derived: sum of 2 quarters · filed 2022-11-09 | $198.85K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $70.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $175.10K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $104.48K 10-Q · filed 2022-05-10 |